Pregledni rad

Treatment of neutropenic fever in patients with malignancies

Toni Valković ; Zavod za hematologiju, kliničku imunologiju i reumatologiju, Klinika za internu medicinu, KBC Rijeka, Rijeka
Gorazd Pilčić ; Zavod za hematologiju, kliničku imunologiju i reumatologiju, Klinika za internu medicinu, KBC Rijeka, Rijeka
Antica Duletić Načinović ; Zavod za hematologiju, kliničku imunologiju i reumatologiju, Klinika za internu medicinu, KBC Rijeka, Rijeka
Ivan Host ; Zavod za hematologiju, kliničku imunologiju i reumatologiju, Klinika za internu medicinu, KBC Rijeka, Rijeka
Duška Petranović ; Zavod za hematologiju, kliničku imunologiju i reumatologiju, Klinika za internu medicinu, KBC Rijeka, Rijeka

Sažetak

Neutropenic fever (NF) is one of the most serious and life threatening complications during the treatment of cancer patients. Low number of neutrophil granulocyte and inadequate immunologic response to infection could lead to various symptoms ranging from very mild deterioration to fast developed of septic shock and finally death of the patient. So, the patient with FN during the therapy of hematologic malignancy must be considered as a medical emergency, and as soon as possible to start with initial empirical antibiotic treatment. We present basic knowledge about NF with short guideliness for its treatment that we use in daily practice with our patients.

Ključne riječi

guidelines; hematologic malignancies; neutropenic fever; therapy

Hrčak ID:

144029

URI

https://hrcak.srce.hr/144029

Datum izdavanja:

1.9.2015.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.969 *